News Focus
News Focus
Post# of 257660
Next 10
Followers 843
Posts 123038
Boards Moderated 9
Alias Born 09/05/2002

Re: drbio45 post# 125426

Sunday, 08/21/2011 6:38:29 PM

Sunday, August 21, 2011 6:38:29 PM

Post# of 257660
If a non-substitutable Lovenox knockoff entered the market, MNTA would continue to get a 45% share of NVS’ Lovenox profits, i.e. the same economics as the current arrangement.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today